Oncology

Breast cancer patients preferred recommendations authored by ChatGPT over those written by physicians, according to a survey conducted by researchers at Albuquerque-based University of New Mexico Comprehensive Cancer Center. Researchers asked 51 adult breast cancer patients and 15 physicians to…

Breast cancer patients with obesity or Type 2 diabetes who used GLP-1s had lower all-cause mortality and risk of recurrence, according to a study published May 11 in JAMA Network Open.  Researchers from Richmond, Va.-based VCU Massey Comprehensive Cancer Center…

Proton therapy outperformed photon therapy among patients with oropharyngeal cancer, according to a study published Jan. 10 in The Lancet. Researchers from 21 U.S. cancer centers conducted a phase 3 trial of 440 patients with oropharyngeal cancer. Patients were randomized…

An AI tool developed by a team of researchers at Los Angeles-based Cedars-Sinai Health Sciences University can perform genetic profiling faster and at a lower cost compared to conventional methods, according to a study published May 8 in Cell.  Called…

The FDA has approved Bizengri for adults with advanced, unresectable or metastatic cholangiocarcinoma harboring a neuregulin 1 gene fusion whose disease progressed on or after prior systemic therapy. Bizengri is the first approved treatment for patients with NRG1 fusion-positive cholangiocarcinoma,…

From outpatient care facilities and specialty clinics to infusion centers and research labs, here are 32 health systems opening cancer centers or expanding oncology services in 2026:

David Strickland has been named regional CIO of Duarte, Calif.-based City of Hope. Mr. Strickland previously worked at Oakland, Calif.-based Kaiser Permanente for nearly 20 years, finishing his time there as vice president of product management and virtual care. He…

New Orleans-based LCMC Health has named Amelia Jernigan, MD, director of the cancer service line. Dr. Jernigan currently serves as medical director of cancer services at University Medical Center New Orleans for LCMC Health and is the Ronald D. Alvarez,…

Less than half of patients ages 65 and older with metastatic non-small cell lung cancer received systemic treatment, according to a study published May 7 in JAMA Oncology.  Researchers from Charleston-based Medical University of South Carolina, Memphis, Tenn.-based Baptist Cancer…

Daraxonrasib, a drug that targets the genetic driver of most pancreatic cancers, extended clinical trial participants’ progression-free survival by a median of 8.5 months, according to a study published May 6 in The New England Journal of Medicine.  Fifteen cancer…